Actinium Pharmaceuticals (ATNM) Stock Chart & Stock Price History $1.16 -0.06 (-4.92%) (As of 05:45 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Actinium Pharmaceuticals Stock Price Performance 5 Day Performance-0.41%1 Month Performance-13.43%3 Month Performance-31.18%6 Month Performance-84.97%Year-To-Date Performance-75.89%1 Year Performance-76.97% Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address U.S. Government: “this could save civilization.” (Ad)Experts indicate that ChatGPT alone consumes up to 17,000 times more electricity than the average U.S. household uses in a single day. And with companies like Google and Microsoft implementing AI into everything we do, that energy consumption is only going to exponentially increase. Thing is, outside of a small group of elite investors, nobody has connected the dots on how this military contractor could be the most important company in the AI boom.To get all the details, go here now. ATNM Stock Chart for Wednesday, December, 18, 2024 ATNM Chart by TradingView Actinium Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$1.28$1.22-4.69%$1.29$1.22294,597 shs$38.06 million12/16/2024$1.23$1.28+4.07%$1.28$1.20381,265 shs$39.93 million12/13/2024$1.25$1.23-1.60%$1.23$1.16433,809 shs$38.38 million12/12/2024$1.28$1.25-2.34%$1.34$1.22284,918 shs$39.00 million12/11/2024$1.30$1.28-1.54%$1.34$1.27306,322 shs$39.93 million12/10/2024$1.33$1.30-1.89%$1.37$1.26391,173 shs$40.56 million Get the Latest News and Ratings for ATNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$1.36$1.33-2.57%$1.40$1.32368,035 shs$41.34 million12/06/2024$1.22$1.36+11.48%$1.38$1.20526,384 shs$42.43 million12/05/2024$1.20$1.22+2.09%$1.26$1.22354,007 shs$38.06 million12/04/2024$1.34$1.20-10.82%$1.33$1.19614,399 shs$37.28 million12/03/2024$1.42$1.34-5.63%$1.41$1.34243,482 shs$41.81 million12/02/2024$1.44$1.42-1.39%$1.44$1.39331,355 shs$44.30 million11/29/2024$1.44$1.45+0.35%$1.49$1.39156,205 shs$45.08 million11/28/2024$1.44$1.44$1.45$1.37206,082 shs$44.92 million11/27/2024$1.41$1.44+2.13%$1.45$1.37206,005 shs$44.93 million11/26/2024$1.46$1.41-3.42%$1.48$1.39296,062 shs$43.99 million11/25/2024$1.45$1.46+0.69%$1.54$1.43286,564 shs$45.55 million11/22/2024$1.47$1.44-2.04%$1.48$1.41222,668 shs$44.93 million11/21/2024$1.39$1.47+5.76%$1.47$1.37277,253 shs$45.86 million11/20/2024$1.44$1.39-3.47%$1.46$1.38286,392 shs$43.36 million11/19/2024$1.42$1.44+1.77%$1.49$1.40313,521 shs$44.92 million11/18/2024$1.50$1.42-5.67%$1.63$1.40371,148 shs$44.15 million Related Companies Adaptimmune Therapeutics Stock Price Chart Puma Biotechnology Stock Price Chart Elutia Stock Price Chart Black Diamond Therapeutics Stock Price Chart Instil Bio Stock Price Chart Monopar Therapeutics Stock Price Chart Telomir Pharmaceuticals Stock Price Chart Compugen Stock Price Chart Galectin Therapeutics Stock Price Chart Atossa Therapeutics Stock Price Chart Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ATNM) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinium Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATNM Stock Alerts